Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Valneva Se ADR
(NQ:
VALN
)
5.990
-0.100 (-1.64%)
Streaming Delayed Price
Updated: 3:32 PM EDT, Oct 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Valneva Se ADR
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Palo Alto Networks To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Friday
October 11, 2024
Via
Benzinga
Expert Ratings For Valneva
October 11, 2024
Via
Benzinga
In-Depth Examination Of 6 Analyst Recommendations For Valneva
September 25, 2024
Via
Benzinga
Adobe, SelectQuote, Similarweb And Other Big Stocks Moving Lower In Friday's Pre-Market Session
September 13, 2024
Via
Benzinga
Pfizer And Valneva Partnered Lyme Disease Vaccine Shows Effectiveness As Booster Shot In Mid-Stage Study
September 03, 2024
Valneva and Pfizer released data from their Phase 2 study of the Lyme disease vaccine candidate VLA15, showing strong immune response and safety profile after a second booster dose, with seroconversion...
Via
Benzinga
The Analyst Landscape: 6 Takes On Valneva
September 03, 2024
Via
Benzinga
Analyst Scoreboard: 8 Ratings For Valneva
August 14, 2024
Via
Benzinga
What Analysts Are Saying About Valneva Stock
July 22, 2024
Via
Benzinga
The Analyst Landscape: 6 Takes On Valneva
June 24, 2024
Via
Benzinga
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 19, 2024
Via
Benzinga
ZIM Integrated Shipping Services Posts Upbeat Earnings, Joins fuboTV, Foghorn Therapeutics And Other Big Stocks Moving Higher On Monday
August 19, 2024
Via
Benzinga
VALN Stock Earnings: Valneva Misses EPS, Misses Revenue for Q2 2024
August 13, 2024
VALN stock results show that Valneva missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
What Analysts Are Saying About Valneva Stock
May 31, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For Valneva
May 08, 2024
Via
Benzinga
What Analysts Are Saying About Valneva Stock
March 22, 2024
Via
Benzinga
VALN Stock Earnings: Valneva Misses Revenue for Q4 2023
March 20, 2024
VALN stock results show that Valneva missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
3 Promising Biotech Stocks You Can Pick Up for Less Than $10
July 29, 2024
Healthcare innovations are big business. That said, biotech stocks under $10 may offer a higher ceiling thanks to their low price.
Via
InvestorPlace
Pfizer/Valneva's Vaccine Study For Tick-Borne Infection Completes Primary Vaccination Series, Plans Approval In 2026
July 18, 2024
Pfizer and Valneva announced the completion of the primary vaccination series in the Phase 3 VALOR trial for their Lyme disease vaccine, VLA15. Participants will be monitored until the end of the 2025...
Via
Benzinga
Valneva Seeks Expanded Use For Its Chikungunya Vaccine In Adolescents With Encouraging Phase 3 Data
May 13, 2024
Valneva released positive Phase 3 data for its single-shot chikungunya virus vaccine in adolescents. The vaccine is also expected to be approved for use in Brazil.
Via
Benzinga
VALN Stock Earnings: Valneva Misses EPS, Misses Revenue for Q1 2024
May 13, 2024
VALN stock results show that Valneva missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
National CineMedia Reports Upbeat Results, Joins Nordstrom, Core & Main And Other Big Stocks Moving Higher On Tuesday
March 19, 2024
U.S. stocks were mixed, with the Dow Jones index gaining around 75 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Expert Ratings for Valneva
December 04, 2023
Via
Benzinga
Analyst Ratings for Valneva
November 10, 2023
Via
Benzinga
Analyst Ratings for Valneva
September 07, 2023
Via
Benzinga
Smith & Wesson Brands Reports Upbeat Earnings, Joins America's Car-Mart, HCI Group And Other Big Stocks Moving Higher On Friday
March 08, 2024
U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Friday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Novavax’s dispute resolution and upcoming earnings call
February 23, 2024
Novavax navigates legal settlements, earnings expectations, and competition, hoping their protein-based vaccines become a global health game-changer.
Via
MarketBeat
Topics
Earnings
Exposures
COVID-19
Financial
Chikungunya Vaccine Maker Valneva Secures Non Dilutive Funding To Develop/Expand Its Clinical Pipeline
February 05, 2024
Valneva sells FDA Priority Review Voucher for $103 million after FDA approval of Ixchiq, the world's first licensed chikungunya vaccine. Proceeds to boost R&D projects.
Via
Benzinga
Exposures
Product Safety
McDonald's, Caterpillar And 3 Stocks To Watch Heading Into Monday
February 05, 2024
With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Valneva Says Single Chikungunya Vaccine Shows Long-Lasting Antibody Response In Younger, Older Adults
December 04, 2023
Valneva SE (NASDAQ: VALN) reported antibody persistence data 24 months after vaccination with a single dose of its chikungunya vaccine IXCHIQ, further supporting the anticipated long-term durability of...
Via
Benzinga
FDA Approves World's First Mosquito-Borne Chikungunya Vaccine
November 10, 2023
The FDA approved Valneva SE's (NASDAQ: VALN) Chikungunya single-dose vaccine in individuals
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.